Exclusive-Novo's Wegovy and Ozempic US advertising spend doubles rival Eli Lilly, data shows
By Harshita Mary Varghese and Patrick Wingrove Jan 28 (Reuters) - Novo Nordisk spent nearly $500 mil...
28th January, 2026
By Harshita Mary Varghese and Patrick Wingrove Jan 28 (Reuters) - Novo Nordisk spent nearly $500 mil...
28th January, 2026
By Michael Erman and Maggie Fick NEW YORK/LONDON, Jan 8 (Reuters) - Global drugmakers face a battle...
8th January, 2026
LONDON, Jan 5 (Reuters) - Britain's medicines regulator said on Monday it was reviewing Novo Nordisk...
5th January, 2026
LONDON, Dec 23 (Reuters) - Novo Nordisk's newly approved weight-loss pill version of Wegovy will be...
23rd December, 2025
ZURICH, Dec 20 (Reuters) - Deals between pharmaceutical companies and Washington to reduce prices fo...
20th December, 2025
ZURICH, Dec 18 (Reuters) - Swiss pharma giants Novartis and Roche on Thursday backed U.S. efforts to...
18th December, 2025
By Dan Levine and Patrick Wingrove Dec 9 (Reuters) - U.S. health regulators informed senior executiv...
9th December, 2025

ZURICH (Reuters) -Switzerland's economy contracted by 0.5% in the third quarter when adjusted for sp...
28th November, 2025

LONDON (Reuters) -Novo Nordisk shares rose 5% on Wednesday after analysts said that U.S. price cuts...
26th November, 2025
By Jacob Gronholt-Pedersen and Stine Jacobsen COPENHAGEN (Reuters) -Novo Nordisk's top shareholder f...
14th November, 2025
COPENHAGEN (Reuters) -Shares in Novo Nordisk <NOVOb.CO> rose in early trade on Monday, after the Weg...
10th November, 2025
COPENHAGEN (Reuters) -Denmark's Novo Nordisk said on Monday it is confident that its proposed takeov...
3rd November, 2025